ERBB2 and triple-negative breast carcinoma: For example, triple-negative breast cancer (TNBC), which lacks receptors for estrogen and progesterone and does not overexpress human epidermal growth factor receptor 2 (HER2), is associated with a significantly higher rate of relapse and lower overall survival rate than other breast cancer subtypes [4].